The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization
- PMID: 17008270
- DOI: 10.1080/14647270600787575
The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization
Abstract
Ovarian hyperstimulation syndrome (OHSS) is a serious and potentially life-threatening complication following ovarian stimulation for in vitro fertilization (IVF). Coasting is the practice whereby the gonadotrophins are withheld and the administration of human chorionic gonadotrophin (hCG) is delayed until serum oestradiol (E2) has decreased to what is considered to be a safe level, to prevent the onset of OHSS. This study aimed to assess the length of coasting on the reproductive outcome in women at risk of developing OHSS. Coasting was undertaken when the serum E2 concentrations were > or = 17000 pmol/L but < 21000 pmol/L. Daily E2 measurements were performed and hCG was administered when hormone levels decreased to < 17000 pmol/L. Eighty-one women who had their stimulation cycles coasted were grouped according to the number of coasting days. Severe OHSS occurred in one case, which represented 1.2% of patients who underwent coasting because of an increased risk of developing the syndrome. No difference was found between cycles coasted for 1 - 3 days and cycles coasted for > or = 4 days in terms of oocyte maturity, fertilization and embryo cleavage rates. Women in whom coasting lasted for > or = 4 days had significantly fewer oocytes retrieved (P < 0.05) and decreased implantation rate (P < 0.05) compared to those coasted for 1 - 3 days. Pregnancy rate/embryo transfer and live birth rate did not differ between groups. In conclusion, coasting appears to decrease the risk of OHSS without compromising the IVF cycle pregnancy outcome. Prolonged coasting is, however, associated with reduced implantation rates, perhaps due to the deleterious effects on the endometrium rather than the oocytes.
Similar articles
-
Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25. Fertil Steril. 2008. PMID: 18439601
-
Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.Hum Reprod. 2005 Nov;20(11):3167-72. doi: 10.1093/humrep/dei180. Epub 2005 Jul 8. Hum Reprod. 2005. PMID: 16006465
-
Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome.Int J Fertil Womens Med. 2003 Jan-Feb;48(1):25-31. Int J Fertil Womens Med. 2003. PMID: 12643517 Clinical Trial.
-
[Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].Gynecol Obstet Fertil. 2005 Sep;33(9):703-12. doi: 10.1016/j.gyobfe.2005.06.011. Gynecol Obstet Fertil. 2005. PMID: 16129645 Review. French.
-
Withholding gonadotropins until human chorionic gonadotropin administration.Semin Reprod Med. 2010 Nov;28(6):486-92. doi: 10.1055/s-0030-1265675. Epub 2010 Nov 16. Semin Reprod Med. 2010. PMID: 21082507 Review.
Cited by
-
Ovarian hyperstimulation syndrome.J Hum Reprod Sci. 2011 May;4(2):70-5. doi: 10.4103/0974-1208.86080. J Hum Reprod Sci. 2011. PMID: 22065820 Free PMC article.
-
Advancing or postponing the day of human chorionic gonadotropin does not matter for the outcome in assisted reproductive technology.J Hum Reprod Sci. 2014 Apr;7(2):107-10. doi: 10.4103/0974-1208.138868. J Hum Reprod Sci. 2014. PMID: 25191023 Free PMC article.
-
Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?Turk J Obstet Gynecol. 2014 Sep;11(3):159-164. doi: 10.4274/tjod.48751. Epub 2014 Sep 15. Turk J Obstet Gynecol. 2014. PMID: 28913010 Free PMC article.
-
Ovarian hyperstimulation syndrome: pathophysiology and prevention.J Assist Reprod Genet. 2010 Feb;27(2-3):121-8. doi: 10.1007/s10815-010-9387-6. Epub 2010 Feb 6. J Assist Reprod Genet. 2010. PMID: 20140640 Free PMC article. Review.
-
A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS.Reprod Med Biol. 2021 Nov 25;21(1):e12429. doi: 10.1002/rmb2.12429. eCollection 2022 Jan. Reprod Med Biol. 2021. PMID: 34934404 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources